Pharmaceuticals, Biotechnology and Life Sciences
– Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored…
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial…
Voluntary agreement will allow millions of Americans to purchase medicines at significantly discounted rates Agreement provides Johnson & Johnson pharmaceutical…
SAN DIEGO–(BUSINESS WIRE)–$ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on…
NEW YORK–(BUSINESS WIRE)–GenNx360 Capital Partners (“GenNx360”), a New York City-based private equity firm investing in middle-market industrial and business services…
Investor Day on January 21, 2026, to present new product vision and AI solutions RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Simulations Plus,…
–Savara Submitted the MOLBREEVI Biologics License Application (BLA) in December 2025 for the Potential Treatment of Autoimmune Pulmonary Alveolar Proteinosis…
Approximately $35 million and $49 million unaudited global net product revenue of EKTERLY (sebetralstat) for the fourth quarter and full…
SASKATOON, Saskatchewan–(BUSINESS WIRE)–The Global Agri-Food Advancement Partnership (GAAP) is pleased to announce the signing of a Memorandum of Understanding (MOU)…
SAN FRANCISCO–(BUSINESS WIRE)–A new peer-reviewed study published in Cytotherapy, the official journal of the International Society for Cell & Gene…